Literature DB >> 2144008

Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations.

M H Holguin1, C B Kurtz, C J Parker, J J Weis, J H Weis.   

Abstract

Analysis of the coding sequences of the murine Cr2 gene indicated that it contains two distinct regions of homology to the murine Crry, and human CR1 and CR2 genes. The last 15 short consensus repeats (SCR) of Cr2 are very similar to the 15 reported SCR of human CR2. These 15 SCR of Cr2, plus the transmembrane and cytoplasmic domains, make up a protein very similar in organization and sequence to the human CR2 gene product. Another Cr2 transcript contains the sequences encoding the previously described 15 SCR plus those encoding another six amino terminal SCR. These amino terminal SCR are very similar to those of Crry and the first six SCR seen within the CR1 long homologous repeats. Amino acid sequence similarity analysis, however, indicated that the sequences encoding the six amino terminal SCR of Cr2 evolved from a separate lineage of SCR than Crry and CR1, suggesting that the human counterparts to these additional Cr2 SCR had not been identified. Using the cDNA sequences specific for the amino terminal SCR of murine Cr2, the human counterparts were isolated and localized within the human CR2 gene between those nucleotides encoding the signal sequence and those encoding the first SCR of the mature human CR2 protein. Unlike the murine Cr2 gene products, these Crry/CR1-like sequences of the CR2 gene are not maintained in mature CR2 mRNA, and thus represent pseudoexons. DNA sequence analysis of the pseudoexon homologous to that encoding the first SCR of the murine Cr2 gene indicated that a stop codon has been introduced within the human coding sequence but that the 5' and 3' splice recognition sequences appear to be functional. Although the stop codon would block the translation of a transcript with this exon, it would not inhibit the incorporation of the exon within the mature CR2 transcript. Therefore, another mutation must have been introduced within the human CR2 gene such that both this exon and the other CR1/Crry-like exons are removed from mature CR2 transcripts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144008

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 2.  Complement receptors and the shaping of the natural antibody repertoire.

Authors:  V Michael Holers
Journal:  Springer Semin Immunopathol       Date:  2004-12-22

3.  Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.

Authors:  Luke R Donius; Christopher M Orlando; Janis J Weis; John H Weis
Journal:  Immunobiology       Date:  2013-08-21       Impact factor: 3.144

4.  Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression.

Authors:  M Guan; R D Zhang; B Wu; E E Henderson
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

5.  Different genomic structure of mouse and human Lmp7 genes: characterization of MHC-encoded proteasome genes.

Authors:  T Meinhardt; U Gräf; G J Hämmerling
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.

Authors:  Luke R Donius; Jennifer M Handy; Janis J Weis; John H Weis
Journal:  J Immunol       Date:  2013-06-03       Impact factor: 5.422

Review 7.  Comparative functional evolution of human and mouse CR1 and CR2.

Authors:  Amanda C Jacobson; John H Weis
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  Murine complement receptor gene expression: Cr2 gene transcripts are depressed during a high dose microbial challenge.

Authors:  S S Tan; E M O'Toole; C B Kurtz; J H Weis
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

9.  Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.

Authors:  A X Delcayre; F Salas; S Mathur; K Kovats; M Lotz; W Lernhardt
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

Review 10.  Transcriptional control of complement receptor gene expression.

Authors:  Brian K Martin
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.